The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Research indicates that ALS, in common with other neurological disorders, such as Alzheimer's and Parkinson's disease, is caused by our own proteins, which form aberrant aggregates that are fatally toxic to our nerve cells. However, it has not been known what causes these proteins to aggregate. Researchers at Lund University have now revealed what happens with proteins during the very first, critical step towards forming larger aggregates.
It turns out that the protein superoxide dismutase interchanges between its normal structure and a misfolded form. During a brief moment the structure becomes partially misfolded to expose sticky patches that normally are hidden in the interior. These patches cause two or several protein molecules to stick together, thereby forming the cornerstone of the larger structures that are believed to underlie ALS.
The research team headed by Mikael Akke at the Center for Molecular Protein Science of Lund University used NMR spectroscopy to create a snapshot of the misfolded structure, which had not previously been seen. Knowledge of the misfolded protein structure potentially makes possible future efforts to rationally design drugs that prevent the misfolding event and hence the development of ALS.
Amyotrophic lateral sclerosis (ALS) is a dreaded and incurable disease that affects nerve cells in the brain and spinal cord, leading to muscle atrophy and respiratory failure. Worldwide, 2 per 100,000 people are diagnosed with ALS each year and 6 per 1 million people suffer from ALS.
The research article "Transient structural distortion of metal-free Cu/Zn superoxide dismutase triggers aberrant oligomerization" will be published online this week in the Proceedings of the National Academy of Sciences of the United States of America (PNAS), Early Edition.
More information: Akke phone +46-46 222 82 47 or Mikael.Akke@bpc.lu.se
Pressofficer Lena Björk Blixt; Lena.Bjork_Blixt@kanslin.lu.se; +46-46222 7186
Lena Björk Blixt | Source: Informationsdienst Wissenschaft
Further information: www.vr.se
Further Reports about: Alzheimer's Disease > Dysfunctional protein dynamics > nerve cell > nerve cells > neurological disease > neurological disorders > NMR spectroscopy > Parkinson's disease > Science TV
More articles from Life Sciences:
Scientists watch as peptides control crystal growth with ‘switches, throttles and brakes’
25.11.2009 | DOE/Lawrence Livermore National Laboratory
Arsenic and Gold Clusters
25.11.2009 | Angewandte Chemie International Edition
First black holes may have incubated in giant, starlike cocoons
25.11.2009 | Physics and Astronomy
KfW issues its first ever 7 year Euro-Benchmark
25.11.2009 | Business and Finance
Intelligence inside metal components
25.11.2009 | Information Technology
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News